THE study of unani drug Majoon e vaj in patients involving inability to recall important personal information that would not typically be lost with ordinary forgetting

Evaluation of the Efficacy of Majoon e Waj in Nisyan-an interventional study without control

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/06/053818

Enrollment

Registered

2023-06-13

Start date

Unknown

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F440- Dissociative amnesia

Interventions

Intervention1: Majoon e Vaj with arq e Badiyan: Vaj Turki Acorous calamus10g Filfilsiyah Piper nigerum 3g Shohneez Nigella sativa 3g Kamooni Carcum carvi 3g Shehtraj Plumbago zeylanica linn 3g Zanjabe

Eligibility

Inclusion criteria

Inclusion criteria: Any gender between 18-46 years of age. Subjects diagnosed as having Dissocative Amnesia along with Dissociative Fugue (DA with DF) on account of DSM 5 criteria, and taking any medication for this. Subjects having sufficient competence to understand and answer the questions of the investigator.

Exclusion criteria

Exclusion criteria: Subjects with ordinary forgetfulness, episodes of trance disorder, possession disorder, partial dissocative identity disorder, any other disorder, or any combination of those disorders. Subjects with tendency of suicidality k/c/o substance abuse, Current life-crisis (i.e., ongoing abuse, divorce, a somatic disease in spouse or children etc.). Subjects with Ongoing psychotic episodes. Neurological diseases, mental disability or life-threatening somatic diseases.

Design outcomes

Primary

Measure	Time frame
Improvement in Autobiographical Memory Intreview(AMI)Timepoint: 2 months	—

Secondary

Measure	Time frame
Decrease in DDIS score Timepoint: 2 months	—

Countries

India

Contacts

Public ContactDr Mohd Aleemudin Quamri

National Institue of Unani Medicine

drmaquamri@gmail.com9341072974

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026